CMDh RECOMMENDATION ON IMPLEMENTATION OF ARTICLE 30 DECISIONS cf. DIRECTIVE[removed]EC, AS AMENDED FOR GENERIC HYBRID BIOSIMILAR MEDICINAL PRODUCTS APPROVED THROUGH MRP DCP Doc. Ref.: CMDh[removed]Revision 4, June 2010 - Directive 2001 83 EC - Document - PDFSEARCH.IO

First Page	Meta Content
	CMDh RECOMMENDATION ON IMPLEMENTATION OF ARTICLE 30 DECISIONS cf. DIRECTIVE[removed]EC, AS AMENDED FOR GENERIC/HYBRID/BIOSIMILAR MEDICINAL PRODUCTS APPROVED THROUGH MRP/DCP Doc. Ref.: CMDh[removed]Revision 4, June 2010 Add to Reading List Document Date: 2013-08-01 09:55:16 Open Document File Size: 111,73 KB Share Result on Facebook IndustryTerm medicinal product / veterinary medicinal products / pharmaceuticals / medicinal products / compound/medicinal product / / Organization Press Office / European Union / Commission Directorate / European Commission / / ProgrammingLanguage EC / / PublishedMedium the CHMP monthly / / Technology html / / URL www.hma.eu/23.html / http / SocialTag Research Pharmaceutical sciences Health European Union Medicinal product Committee for Medicinal Products for Human Use Summary of Product Characteristics Referral marketing Directive 2001/83/EC Clinical research

CMDh RECOMMENDATION ON IMPLEMENTATION OF ARTICLE 30 DECISIONS cf. DIRECTIVE[removed]EC, AS AMENDED FOR GENERIC/HYBRID/BIOSIMILAR MEDICINAL PRODUCTS APPROVED THROUGH MRP/DCP Doc. Ref.: CMDh[removed]Revision 4, June 2010Add to Reading List